Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature.

This improvement in LVEDD was seen across studies enrolling patients with non‐ischaemic or mixed aetiology patients, −5.2 and −3.7 mm, respectively ( Figure 5 and Figure S8 ), but did not reach statistical significance individually in either group individually.

also in 111,027 other papers